BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17625728)

  • 1. Vancomycin use in a hospital with high prevalence of methicillin-resistant Staphylococcus aureus: comparison with Hospital Infection Control Practices Advisory Committe Guidelines (HICPAC).
    Melo DO; Sasaki M; Grinbaum RS
    Braz J Infect Dis; 2007 Feb; 11(1):53-6. PubMed ID: 17625728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin use in a Brazilian teaching hospital: comparison with the Hospital Infection Controlpractices Advisory Committee Guidelines (HICPAC).
    Melo DO; Ribeiro E
    Braz J Infect Dis; 2009 Jun; 13(3):161-4. PubMed ID: 20191189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines.
    Evans ME; Kortas KJ
    Infect Control Hosp Epidemiol; 1996 Jun; 17(6):356-9. PubMed ID: 8805065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycopeptide prescribing in a tertiary referral paediatric hospital and applicability of hospital infection control practices advisory committee (HICPAC) guidelines to children.
    Nourse C; Byrne C; Leonard L; Butler K
    Eur J Pediatr; 2000 Mar; 159(3):193-7. PubMed ID: 10664234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices.
    Rubin LG; Sánchez PJ; Siegel J; Levine G; Saiman L; Jarvis WR;
    Pediatrics; 2002 Oct; 110(4):e42. PubMed ID: 12359815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin use in hospitalized pediatric patients.
    Keyserling HL; Sinkowitz-Cochran RL; Harris JM; Levine GL; Siegel JD; Stover BH; Lau SA; Jarvis WR;
    Pediatrics; 2003 Aug; 112(2):e104-11. PubMed ID: 12897315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasi-experimental study in a region of high MRSA prevalence.
    Choe PG; Koo HL; Yoon D; Bae JY; Lee E; Hwang JH; Song KH; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Oh MD; Kim NJ
    BMC Infect Dis; 2018 Apr; 18(1):178. PubMed ID: 29661158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.
    Garrouste-Orgeas M; Timsit JF; Kallel H; Ben Ali A; Dumay MF; Paoli B; Misset B; Carlet J
    Infect Control Hosp Epidemiol; 2001 Nov; 22(11):687-92. PubMed ID: 11842988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.
    Roghmann MC
    Arch Intern Med; 2000 Apr; 160(7):1001-4. PubMed ID: 10761966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control.
    Monnet DL
    Infect Control Hosp Epidemiol; 1998 Aug; 19(8):552-9. PubMed ID: 9758054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases.
    Sgarabotto D; Cusinato R; Narne E; Scano F; Zignol M; Gambino A; Cattelan A; Meneghetti F; Cadrobbi P
    Scand J Infect Dis; 2002; 34(2):122-6. PubMed ID: 11928842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing pattern of vancomycin in a community teaching hospital with low prevalence of vancomycin-resistant enterococci.
    Watanakunakorn C
    Infect Control Hosp Epidemiol; 1997 Nov; 18(11):767-9. PubMed ID: 9397372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant Staphylococcus aureus infections.
    Kumana CR; Ching TY; Kong Y; Ma EC; Kou M; Lee RA; Cheng VC; Chiu SS; Seto WH
    Br J Clin Pharmacol; 2001 Oct; 52(4):427-32. PubMed ID: 11678786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical decision process model for evaluating vancomycin use with modified HICPAC guidelines. Hospital Infection Control Practice Advisory Committee.
    Salemi C; Becker L; Morrissey R; Warmington J
    Clin Perform Qual Health Care; 1998; 6(1):12-6. PubMed ID: 10177043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive staphylococcus aureus surgical site infections: report from Australian Surveillance Data (VICNISS).
    Bull AL; Worth LJ; Richards MJ
    Ann Surg; 2012 Dec; 256(6):1089-92. PubMed ID: 22824854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to international antimicrobial prophylaxis guidelines in cardiac surgery: a Jordanian study demonstrates need for quality improvement.
    Al-Momany NH; Al-Bakri AG; Makahleh ZM; Wazaify MM
    J Manag Care Pharm; 2009 Apr; 15(3):262-71. PubMed ID: 19326957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus.
    Tacconelli E; Cataldo MA; Albanese A; Tumbarello M; Arduini E; Spanu T; Fadda G; Anile C; Maira G; Federico G; Cauda R
    J Hosp Infect; 2008 Aug; 69(4):337-44. PubMed ID: 18602187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy in Intensive Care Unit Patients.
    Chotiprasitsakul D; Tamma PD; Gadala A; Cosgrove SE
    Infect Control Hosp Epidemiol; 2018 Mar; 39(3):290-296. PubMed ID: 29374504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of mecA gene and borderline oxacillin resistant Staphylococcus aureus in nosocomial acquired methicillin resistance Staphylococcus aureus infections.
    Khorvash F; Mostafavizadeh K; Mobasherizadeh S
    Pak J Biol Sci; 2008 May; 11(9):1282-5. PubMed ID: 18819540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.